Jeffrey L. Rutherford - Jan 29, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP and CFO
Signature
Jonathan B. Leiken, Attorney-in-fact for Jeffrey L. Rutherford
Stock symbol
DBD
Transactions as of
Jan 29, 2022
Transactions value $
-$160,987
Form type
4
Date filed
1/31/2022, 03:44 PM
Next filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Tax liability -$124K -14.1K -5.62% $8.80 236K Jan 29, 2022 Direct F1, F2
transaction DBD Common Shares Tax liability -$37.1K -4.22K -1.78% $8.80 232K Jan 30, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 68.6K Jan 29, 2022 Common Shares 68.6K $4.08 Direct F3
holding DBD Non-Qualified Stock Option 18.9K Jan 29, 2022 Common Shares 18.9K $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2 Number includes restricted stock units.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.